Jan Harder

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

Anja Rinke, Hans‐Helge Müller, Carmen Schade‐Brittinger et al. · Journal of Clinical Oncology · 2009 · 2.5K citations

Medicine, Oncology, Pharmacotherapy +17

Phase I Clinical Study of AZD2171, an Oral Vascular Endothelial Growth Factor Signaling Inhibitor, in Patients With Advanced Solid Tumors

Joachim Drevs, Patrizia Siegert, Michael Medinger et al. · Journal of Clinical Oncology · 2007 · 302 citations

Pharmacy, Oncology, Pharmacology +17

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

Jan Harder, Gabriele Ihorst, Volker Heinemann et al. · British Journal of Cancer · 2012 · 184 citations · Full text

Medicine, Oncology, Pharmacology +17

Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer

Jan Harder, Bettina Riecken, Oliver Kummer et al. · British Journal of Cancer · 2006 · 123 citations · Full text

Medicine, Oncology, Pharmacology +15

EGFR and HER2 expression in advanced biliary tract cancer

Jan Harder, Oliver Waiz, Florian Otto et al. · World Journal of Gastroenterology · 2009 · 121 citations · Full text

Medicine, Oncology, Pathology +17